Hide metadata

dc.date.accessioned2023-01-21T18:01:49Z
dc.date.available2023-01-21T18:01:49Z
dc.date.created2022-08-31T09:50:40Z
dc.date.issued2022
dc.identifier.citationØvrebotten, Tarjei Myhre, Peder Langeland Grimsmo, Jostein Mecinaj, Albulena Trebinjac, Divna Nossen, Magnus Berger Andrup, Simon Johan Mattias Josefsen, Tony Andre Einvik, Gunnar Stavem, Knut Omland, Torbjørn Ingul, Charlotte Ingeborg Björk . Changes in cardiac structure and function from 3 to 12 months after hospitalization for COVID-19. Clinical Cardiology. 2022, 45(10), 1044-1052
dc.identifier.urihttp://hdl.handle.net/10852/99051
dc.description.abstractBackground Cardiac function may be impaired during and early after hospitalization for COVID-19, but little is known about the progression of cardiac dysfunction and the association with postacute COVID syndrome (PACS). Methods In a multicenter prospective cohort study, patients who had been hospitalized with COVID-19 were enrolled and comprehensive echocardiography was performed 3 and 12 months after discharge. Twenty-four-hour electrocardiogram (ECG) was performed at 3 and 12 months in patients with arrhythmias at 3 months. Results In total, 182 participants attended the 3 and 12 months visits (age 58 ± 14 years, 59% male, body mass index 28.2 ± 4.2 kg/m2). Of these, 35 (20%) had severe COVID-19 (treatment in the intensive care unit) and 74 (52%) had self-reported dyspnea at 3 months. From 3 to 12 months there were no significant overall changes in any measures of left or right ventricle (LV; RV) structure and function (p > .05 for all), including RV strain (from 26.2 ± 3.9% to 26.5 ± 3.1%, p = .29) and LV global longitudinal strain (from 19.2 ± 2.3% to 19.3 ± 2.3%, p = .64). Changes in echocardiographic parameters from 3 to 12 months did not differ by COVID-19 severity or by the presence of persistent dyspnea (p > .05 for all). Among patients with arrhythmia at 3 months, there was no significant change in arrhythmia burden to 12 months. Conclusion Following COVID-19, cardiac structure and function remained unchanged from 3 to 12 months after the index hospitalization, irrespective of COVID-19 severity and presence of persistent dyspnea. These results suggest that progression of cardiac dysfunction after COVID-19 is rare and unlikely to play an important role in PACS.
dc.languageEN
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleChanges in cardiac structure and function from 3 to 12 months after hospitalization for COVID-19
dc.title.alternativeENEngelskEnglishChanges in cardiac structure and function from 3 to 12 months after hospitalization for COVID-19
dc.typeJournal article
dc.creator.authorØvrebotten, Tarjei
dc.creator.authorMyhre, Peder Langeland
dc.creator.authorGrimsmo, Jostein
dc.creator.authorMecinaj, Albulena
dc.creator.authorTrebinjac, Divna
dc.creator.authorNossen, Magnus Berger
dc.creator.authorAndrup, Simon Johan Mattias
dc.creator.authorJosefsen, Tony Andre
dc.creator.authorEinvik, Gunnar
dc.creator.authorStavem, Knut
dc.creator.authorOmland, Torbjørn
dc.creator.authorIngul, Charlotte Ingeborg Björk
cristin.unitcode185,90,0,0
cristin.unitnameUniversitetet i Oslo
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.cristin2047440
dc.identifier.bibliographiccitationinfo:ofi/fmt:kev:mtx:ctx&ctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Clinical Cardiology&rft.volume=45&rft.spage=1044&rft.date=2022
dc.identifier.jtitleClinical Cardiology
dc.identifier.volume45
dc.identifier.issue10
dc.identifier.startpage1044
dc.identifier.endpage1052
dc.identifier.doihttps://doi.org/10.1002/clc.23891
dc.type.documentTidsskriftartikkel
dc.type.peerreviewedPeer reviewed
dc.source.issn0160-9289
dc.type.versionPublishedVersion


Files in this item

Appears in the following Collection

Hide metadata

Attribution 4.0 International
This item's license is: Attribution 4.0 International